Clinical trial of 20% Mat lippia (bucan) topical ointment for cutaneous leishmaniasis; a preliminary trial
Keywords:
Mat lippia ointment, leishmaniasisAbstract
Background Cutaneous leishmaniasis is endemic in many parts of Pakistan. The mainstay oftreatment is systemic pentavalent antimonials. However, many indigenous plants are alsoused for its treatment.Objective To test the hypothesis that Mat lippia (Bucan), a local plant, may be topicallyeffective in the treatment of cutaneous leishmaniasis.Patients and methods The study comprised of two parts. Part 1: An alcoholic extract fromthe leaves of the plant was obtained and then 20% ointment in petroleum jelly was made. Inpart 2, eighty patients of cutaneous leishmaniasis were treated with this ointment appliedthrice daily for six weeks. Patients were followed up initially twice a week and then atweekly intervals for six weeks.Results 60% showed excellent response and 20% exhibited fair improvement.Conclusion 20% Mat lippia ointment seems to be effective in the treatment of leishmaniasis.However, further comparative studies are warranted to confirm these findings.References
The Leishmaniasis. Report of a WHO
Expert Committee. Technical Report
Series No. 701. Geneva: WHO; 1984. p.
-140.
Control of the Leishmaniasis. Report of a
WHO Expert Committee. Technical
Report Series No. 793. Geneva: WHO;
p. 1-158.
Bosan AH, Amanullah M, Dil AS. The
efficacy of intralesional treatment of
cutaneous leishmaniasis with glucantime.
Pak J Med Res 2002; 41: 54-7.
Pathan GM, Soomro FR. Cutaneous
leishmaniasis in a village of mountainous
belt of Larkana District. J Pak Assoc
Dermatol 2001; 11: 16-9.
Soomro FR, Pathan GM, Soomro RA. The
patterns of cutaneous leishmaniasis and
differential diagnosis of misdiagnosed
cases in Larkana Region. J Pak Assoc
Dermatol 2002; 12: 77- 82.
Soomro FR, Pathan GM, Bhutto AM et al.
A preliminary survey on cutaneous
leishmaniasis at village Gaibi Dero
Larkana District, Sindh, Pakistan. Studies
on New and Old World leishmaniases and
their transmission, with particular
reference to Ecuador, Argentina and
Pakistan. Research Report Series No. 7.
Kochi: Kochi Medical School; 2004.
Khan IK, Khan MA. Managing cutaneous
leishmaniasis from Peru to Pakistan. J Pak
Assoc Dermatol 2000; 10: 5-15.
Ravishankar, B, Makwana HJ, Nair RB,
Vijayan NP. Pharmacological Studies on
Lippia nodiflora mich. Part A-Petroleum,
ether and chloroform extracts. J Res
Auryveda Sinddha 1980; 10: 141-52.
Ajmal M, Bhutto AH. Antimicrobial
activity of non-alkaloidal constituents of
Lippia nodiflora (Thesis). Karachi:
Institute of Pharmacy: University of
Sindh; 2002.
Akhter FM. Chemical and biological
investigation of medicinal herbs. Karachi:
Department of Pharmacognosy, Faculty of
Pharmacy, University of Karachi; 1993.
Elakouich SD, Steven KL. Volatile
constitute of Lippia-nodiflora. J Nat
Products 1985; 58: 504-6.
Joshi. BC, Parishad V. Chemical
examination of Lippia nodiflora. J Sci
Industr Res 1959; 18: 527-37.
Monforte, MT, Ragus S, Trovato A,
Foresteieri AM. Antiinflammatory,
analgesic and antipyretic activity in
rodents of plant extracts used in African
Medicine. Photother Res 1996; 10: 100-6.
Cheesbrogh M, ed. Medical Laboratory
Manual for Tropical Countries, 2nd edn.
Butterworth: Cambridge Tropical Health
Technology; 1987.
Saeed HM, ed. 1970 Hamdard
Pharmacopoea of Eastern Medicine, 2nd
impression. Karachi: Hamdard
Foundation; 1970.
Dynmack W, ed. Pharmacographia India.
Karachi: Hamdard Foundation; 1972. 57-
Bhandari MM. Flora of the Indian Desert.
Jodhupur: Scientific Publishers; 1978.
Zargaria A. Medicinal Plants, 5th edition.
Tehran: Department of Pharmacognosy,
College of Pharmacy Tehran University of
Medical Sciences; 1992. Iran 889.
Ashraf TA, Mohammad L, Salama F,
Osman M. Phenolic compounds from
Lippia nodiflora. Mansoura J Pharma Sci
; 11: 256-65.
